Understanding GLP‑1: how hunger hormones affect weight loss in women

What is GLP‑1?

GLP‑1 (glucagon‑like peptide‑1) is a hormone produced in the gut in response to food. It acts as one of the body’s many chemical messengers that help regulate appetite, digestion and blood sugar. In plain terms, GLP‑1 helps communicate to the brain and organs that you’ve eaten and can affect how full you feel and how quickly food is processed.

For a supplement perspective see our For a supplement perspective see our Venus Factor review.

How GLP‑1 influences appetite and eating behaviour

GLP‑1 is released after meals and interacts with receptors in the brain, particularly areas involved in hunger and reward. This interaction is thought to reduce appetite and food intake in some people. It can also slow gastric emptying — the rate at which the stomach passes food into the intestines — which may contribute to a prolonged feeling of fullness after eating.

Effects on blood sugar and metabolism

GLP‑1 stimulates insulin release when blood glucose is high and decreases the release of glucagon, a hormone that raises blood sugar. These actions are part of how the body keeps blood glucose within a normal range after meals. Drug treatments that act on GLP‑1 receptors were developed for blood sugar control and have also been observed to affect body weight.

Why does GLP‑1 matter for women in particular?

Menstrual cycle, pregnancy, menopause and differences in body composition mean that women’s appetite and metabolism can fluctuate in ways distinct from men’s. Research indicates that hormones — including sex hormones such as oestrogen — interact with appetite-regulating systems. As a result, GLP‑1’s effects on hunger and fullness may vary across the life course and between individuals.

Some practical implications for women include:

• Hunger and cravings can change across the menstrual cycle, which may alter how strongly GLP‑1 related signals are perceived.
• Menopause and falling oestrogen levels are associated with changes in body fat distribution and appetite regulation; this can influence responses to appetite-regulating hormones.
• Pregnancy involves large hormonal shifts; GLP‑1 pathways are not the primary driver of pregnancy appetite changes and many interventions are not suitable in pregnancy or breastfeeding.

GLP‑1 receptor agonists: prescription medicines

Certain prescription medicines called GLP‑1 receptor agonists (GLP‑1 RAs) mimic the action of the natural hormone. They were originally developed to manage blood sugar in type 2 diabetes and are now also prescribed for weight management in some people. Makers and prescribers market these drugs as helping to reduce appetite, slow gastric emptying and assist weight loss when combined with lifestyle changes.

It’s important to note that while many people experience benefits, these medicines can cause side effects such as nausea or digestive upset, and they require medical assessment and ongoing clinical supervision. They are prescription-only in the UK and suitability must be checked with a healthcare professional.

What about over‑the‑counter supplements?

Many products on the market are promoted to support weight management. Manufacturers sometimes claim ingredients will “boost GLP‑1” or mimic its actions. Such claims should be viewed cautiously: supplements are not subject to the same testing and regulation as prescription medicines, and the evidence base for specific products varies widely. The maker of any product may present research selectively; independent clinical trials are the most reliable source of benefit and safety information.

Practical ways to work with appetite hormones

While hormonal systems are complex, some lifestyle approaches can support appetite regulation and metabolic health:

• Prioritise protein and fibre at meals to support satiety.
• Regular physical activity can influence appetite regulation over time and supports metabolic health.
• Manage sleep and stress — both can affect hunger hormones and eating patterns.
• Avoid extreme dieting. Severe calorie restriction can disrupt appetite regulation and make it harder to maintain weight loss.

These measures do not directly “raise” GLP‑1 in a targeted way like a drug can, but they help create a context in which appetite-regulating systems work better.

When to see a professional

Seek medical advice if you have unexplained weight change, persistent appetite disturbances, or health conditions such as diabetes. Discuss any interest in prescription GLP‑1 medicines or supplements with your GP to ensure safety and appropriateness.

This article aims to explain mechanisms and options in plain terms; it does not replace personalised clinical advice.

Medical disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice.

Related reading

• Venus Factor review: full verdict
• Weight management for women over 40: effective strategies and diet plans
• How to choose safe weight‑loss supplements: red flags and evidence to look for